» Articles » PMID: 32218640

Overview
Specialty Pediatrics
Date 2020 Mar 29
PMID 32218640
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Evaluating the guideline 'Diagnosis and treatment of respiratory syncytial (RS) virus bronchiolitis' on the number of chest X-rays, C-reactive proteïn (CRP) counts, leukocyte counts, and antibiotic prescriptions in infants admitted to hospital with RS bronchiolitis.

Design: Retrospective 'before-after' cohort study.

Location: Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.

Patients: Infants admitted with proven RS virus infection.

Methods: Guidelines, including sound restriction of performance of X-rays, CRP and leukocytes, were introduced in February 2003. Data from infants admitted with RS virus infection during 1997- 1999 (cohort A) were compared with those admitted from 2003- April 2006 (cohort B)Results: There were 155 infants in cohort A and 170 in cohort B. Implementation of guidelines led to significant reductions of CRP and leukocyte determinations: 49.0% and 48.2%, respectively (both p<0.001) and X-rays: 30.3% (p=0.020). Numbers of antibiotic prescriptions decreased with 55% (p<0.001). The chance of antibiotic prescription increased significantly when X-rays (OR=5.2), CRP (OR=5.4), or leukocytes (OR=4.2) were done. After implementation of the guidelines, the median stay in hospital decreased significantly from 8.0 to 6.0 days (p<0.001; ranges 1-13 days and 2-23 days, respectively). Performing X-ray, CRP or leukocytes, or antibiotic prescription did not significantly alter the total duration of hospital stay.

Conclusion: Implementation of the guidelines led to significant decreases in numbers of X-rays, CRP and leukocytes determinations, and antibiotic prescriptions. Our data support the restrictive use of chest X-rays, CRP and leukocyte determinations in infants, admitted to hospital with RS virus bronchiolitis.

References
1.
Levine D, Platt S, Dayan P, Macias C, Zorc J, Krief W . Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004; 113(6):1728-34. DOI: 10.1542/peds.113.6.1728. View

2.
Perlstein P, Kotagal U, Schoettker P, Atherton H, Farrell M, Gerhardt W . Sustaining the implementation of an evidence-based guideline for bronchiolitis. Arch Pediatr Adolesc Med. 2000; 154(10):1001-7. DOI: 10.1001/archpedi.154.10.1001. View

3.
Swingler G, Hussey G, Zwarenstein M . Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet. 1998; 351(9100):404-8. DOI: 10.1016/S0140-6736(97)07013-X. View

4.
Purcell K, Fergie J . Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2004; 23(3):267-9. DOI: 10.1097/01.inf.0000116759.21252.29. View

5.
Nagayama Y, Tsubaki T, Nakayama S, Sawada K, Taguchi K, Tateno N . Gender analysis in acute bronchiolitis due to respiratory syncytial virus. Pediatr Allergy Immunol. 2006; 17(1):29-36. DOI: 10.1111/j.1399-3038.2005.00339.x. View